Susquehanna Fundamental Investments’s Revolution Medicines RVMD Stock Holding History

Susquehanna Fundamental Investments’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30,200	Closed	-$1.07M	–	964
2025 Q1	$1.07M	Sell	30,200 -198,313	-87%	-$8.05M	0.01%	678
2024 Q4	$10M	Buy	+228,513	New	+$11.5M	0.14%	194
2024 Q2	$8.87M	Buy	228,513 +22,000	+11%	+$822K	0.2%	142
2024 Q1	$6.66M	Buy	+206,513	New	+$6.12M	0.31%	83
2022 Q4	–	Sell	-13,849	Closed	-$273K	–	1445
2022 Q3	$273K	Buy	+13,849	New	+$304K	﹤0.01%	1186
2022 Q1	$654K	Buy	25,649 +10,048	+64%	+$219K	0.01%	985
2021 Q4	$393K	Buy	+15,601	New	+$440K	0.01%	1011

Other funds holding RVMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Susquehanna Fundamental Investments's RVMD Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Revolution Medicines (RVMD) in Q2 2025, closing a stake of 30,200 shares — an estimated $1.07M sold.

Susquehanna Fundamental Investments first reported a position in RVMD in Q4 2021 and held it in 7 quarters. The position peaked at $10M in Q4 2024. 308 funds tracked by Wall St. Rank hold RVMD as of Q2 2025.

Susquehanna Fundamental Investments reported no remaining Revolution Medicines position as of Q2 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 30,200 Revolution Medicines shares in Q2 2025, an estimated $1.07M.
Susquehanna Fundamental Investments first reported a position in Revolution Medicines in Q4 2021 and held it in 7 quarters.
Susquehanna Fundamental Investments's Revolution Medicines position peaked at $10M in Q4 2024.
308 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.